{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:06:27Z","timestamp":1791223587813,"version":"4.1.0"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland (SFI)","doi-asserted-by":"crossref","award":["12\/IA\/1421"],"award-info":[{"award-number":["12\/IA\/1421"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"crossref"}]},{"name":"SFI Research Centre, Advanced Materials and BioEngineering Research (AMBER)","award":["SFI\/12\/RC\/2278"],"award-info":[{"award-number":["SFI\/12\/RC\/2278"]}]},{"name":"European Union FP7","award":["FP7-SME-2012-1"],"award-info":[{"award-number":["FP7-SME-2012-1"]}]},{"DOI":"10.13039\/501100001597","name":"Irish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001597","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advanced Drug Delivery Reviews"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.addr.2015.03.007","type":"journal-article","created":{"date-parts":[[2015,5,9]],"date-time":"2015-05-09T07:35:24Z","timestamp":1431156924000},"page":"52-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":153,"special_numbering":"C","title":["Delivery strategies to enhance oral vaccination against enteric infections"],"prefix":"10.1016","volume":"91","author":[{"given":"Christopher J.H.","family":"Davitt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3167-1080","authenticated-orcid":false,"given":"Ed C.","family":"Lavelle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.addr.2015.03.007_bb0005","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/01.mcg.0000177231.13770.07","article-title":"Infectious diarrhea in developed and developing countries","volume":"39","author":"Cheng","year":"2005","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2015.03.007_bb0010","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1016\/S0140-6736(12)60560-1","article-title":"W.H.O. Child Health Epidemiology Reference Group of, Unicef, Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000","volume":"379","author":"Liu","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.03.007_bb0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1172\/JCI34005","article-title":"Enteric infections, diarrhea, and their impact on function and development","volume":"118","author":"Petri","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.03.007_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0140-6736(13)60844-2","article-title":"Burden and aetiology of diarrhoeal disease in infants and young children in developing countries (the Global Enteric Multicenter Study, GEMS): a prospective, case\u2013control study","volume":"382","author":"Kotloff","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.03.007_bb0025","first-page":"188","article-title":"From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development","volume":"133","author":"Svennerholm","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb0030","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s00253-012-3930-6","article-title":"Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates","volume":"93","author":"Tobias","year":"2012","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.addr.2015.03.007_bb0035","doi-asserted-by":"crossref","first-page":"4645","DOI":"10.1128\/AEM.71.8.4645-4654.2005","article-title":"Critical factors influencing the occurrence of Vibrio cholerae in the environment of Bangladesh","volume":"71","author":"Huq","year":"2005","journal-title":"Appl. Environ. Microbiol."},{"key":"10.1016\/j.addr.2015.03.007_bb0045","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2165\/11206860-000000000-00000","article-title":"Live attenuated influenza vaccine (FluMist(R); Fluenz): a review of its use in the prevention of seasonal influenza in children and adults","volume":"71","author":"Carter","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.addr.2015.03.007_bb0050","doi-asserted-by":"crossref","first-page":"e1006","DOI":"10.1371\/journal.pntd.0001006","article-title":"Use of oral cholera vaccines in an outbreak in Vietnam: a case control study","volume":"5","author":"Anh","year":"2011","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0055","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.3201\/eid1711.110822","article-title":"Considerations for oral cholera vaccine use during outbreak after earthquake in Haiti, 2010\u20132011","volume":"17","author":"Date","year":"2011","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0060","first-page":"181","article-title":"Mucosal vaccines for biodefense","volume":"354","author":"Mantis","year":"2012","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0065","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/08998280.2005.11928028","article-title":"Edward Jenner and the history of smallpox and vaccination","volume":"18","author":"Riedel","year":"2005","journal-title":"Proc. (Baylor Univ. Med. Cent.)"},{"key":"10.1016\/j.addr.2015.03.007_bb0070","series-title":"Janeway's immunobiology","author":"Murphy","year":"2008"},{"key":"10.1016\/j.addr.2015.03.007_bb0075","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1056\/NEJMp1407783","article-title":"Achieving and maintaining polio eradication\u2013new strategies","volume":"371","author":"Modlin","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0080","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/clinids\/14.2.568","article-title":"Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease","volume":"14","author":"Strebel","year":"1992","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1741-7007-8-129","article-title":"Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine","volume":"8","author":"Levine","year":"2010","journal-title":"BMC Biol."},{"key":"10.1016\/j.addr.2015.03.007_bb0090","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1016\/j.vaccine.2004.12.029","article-title":"Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries","volume":"23","author":"Walker","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0095","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nri3251","article-title":"Recent progress in mucosal vaccine development: potential and limitations","volume":"12","author":"Lycke","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0100","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0140-6736(05)79439-3","article-title":"Optimism over vaccines administered via mucosal surfaces","volume":"351","author":"Levine","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.03.007_bb0105","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1586\/erv.09.61","article-title":"Mucosal vaccines: novel advances in technology and delivery","volume":"8","author":"Yuki","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2015.03.007_bb0110","doi-asserted-by":"crossref","first-page":"19ra12","DOI":"10.1126\/scitranslmed.3000490","article-title":"Long-term thermostabilization of live poxviral and adenoviral vaccine vectors at supraphysiological temperatures in carbohydrate glass","volume":"2","author":"Alcock","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0115","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ijpharm.2013.02.057","article-title":"An approach to a cold chain free oral cholera vaccine: in vitro and in vivo characterization of Vibrio cholerae gastro-resistant microparticles","volume":"448","author":"Pastor","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.03.007_bb0120","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1146\/annurev.immunol.14.1.275","article-title":"Antigen sampling across epithelial barriers and induction of mucosal immune responses","volume":"14","author":"Neutra","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0125","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1038\/nm1213","article-title":"Mucosal immunity and vaccines","volume":"11","author":"Holmgren","year":"2005","journal-title":"Nat. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0130","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1600-065X.2010.00970.x","article-title":"Immunology of gut mucosal vaccines","volume":"239","author":"Pasetti","year":"2011","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0135","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(14)60934-X","article-title":"Effect of a single inactivated poliovirus vaccine dose on intestinal immunity against poliovirus in children previously given oral vaccine: an open-label, randomised controlled trial","volume":"384","author":"John","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.addr.2015.03.007_bb0140","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.coi.2012.03.014","article-title":"Vaccines against mucosal infections","volume":"24","author":"Holmgren","year":"2012","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpg.2007.11.002","article-title":"The mucosal immune system at the gastrointestinal barrier","volume":"22","author":"Schenk","year":"2008","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.addr.2015.03.007_bb0150","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1073\/pnas.0608611104","article-title":"Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus","volume":"104","author":"Lai","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.addr.2008.09.008","article-title":"Barrier properties of mucus","volume":"61","author":"Cone","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0160","doi-asserted-by":"crossref","first-page":"D1321","DOI":"10.2741\/A684","article-title":"Mucins in the gastrointestinal tract in health and disease","volume":"6","author":"Corfield","year":"2001","journal-title":"Front. Biosci."},{"key":"10.1016\/j.addr.2015.03.007_bb0165","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.addr.2008.11.002","article-title":"Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues","volume":"61","author":"Lai","year":"2009","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0170","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0175","doi-asserted-by":"crossref","first-page":"11196","DOI":"10.1128\/JVI.01899-08","article-title":"Human immunodeficiency virus type 1 is trapped by acidic but not by neutralized human cervicovaginal mucus","volume":"83","author":"Lai","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.addr.2015.03.007_bb0180","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1038\/nri1777","article-title":"Mucosal vaccines: the promise and the challenge","volume":"6","author":"Neutra","year":"2006","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0185","doi-asserted-by":"crossref","first-page":"G341","DOI":"10.1152\/ajpgi.00046.2013","article-title":"Studies of mucus in mouse stomach, small intestine, and colon. I. Gastrointestinal mucus layers have different properties depending on location as well as over the Peyer's patches","volume":"305","author":"Ermund","year":"2013","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.addr.2015.03.007_bb0190","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bdd.2510160502","article-title":"Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals","volume":"16","author":"Kararli","year":"1995","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.addr.2015.03.007_bb0195","first-page":"71","article-title":"Determinants of responses to oral vaccines in developing countries","volume":"66","author":"Sack","year":"2008","journal-title":"Ann. Nestle Eng."},{"key":"10.1016\/j.addr.2015.03.007_bb0200","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.4049\/jimmunol.1101248","article-title":"Vitamin A deficiency impairs vaccine-elicited gastrointestinal immunity","volume":"187","author":"Kaufman","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0205","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.it.2014.07.003","article-title":"Influence of the microbiota on vaccine effectiveness","volume":"35","author":"Valdez","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1126\/science.1102901","article-title":"CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance","volume":"307","author":"Niess","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.03.007_bb0215","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/86373","article-title":"Dendritic cells express tight junction proteins and penetrate gut epithelial monolayers to sample bacteria","volume":"2","author":"Rescigno","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0220","doi-asserted-by":"crossref","first-page":"6110","DOI":"10.1073\/pnas.0400969101","article-title":"Intestinal villous M cells: an antigen entry site in the mucosal epithelium","volume":"101","author":"Jang","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0225","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1128\/IAI.66.8.3758-3766.1998","article-title":"Interactions of the invasive pathogens Salmonella typhimurium, Listeria monocytogenes, and Shigella flexneri with M cells and murine Peyer's patches","volume":"66","author":"Jensen","year":"1998","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0230","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature10863","article-title":"Goblet cells deliver luminal antigen to CD103+ dendritic cells in the small intestine","volume":"483","author":"McDole","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.03.007_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0092-8674(00)80106-3","article-title":"Epithelial M cells: gateways for mucosal infection and immunization","volume":"86","author":"Neutra","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.03.007_bb0240","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/mi.2013.30","article-title":"Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium","volume":"6","author":"Mabbott","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0245","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2174\/157339510790231798","article-title":"Microencapsulation of vaccine antigens and adjuvants for mucosal targeting","volume":"6","author":"Thejani","year":"2010","journal-title":"Curr. Immunol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0250","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1128\/IAI.67.2.946-953.1999","article-title":"Human intestinal M cells display the sialyl Lewis A antigen","volume":"67","author":"Giannasca","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0255","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1084\/jem.134.1.188","article-title":"Peyer's patches: an enriched source of precursors for IgA-producing immunocytes in the rabbit","volume":"134","author":"Craig","year":"1971","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0260","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.4049\/jimmunol.172.10.6259","article-title":"IgA class switch occurs in the organized nasopharynx- and gut-associated lymphoid tissue, but not in the diffuse lamina propria of airways and gut","volume":"172","author":"Shikina","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0265","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature08529","article-title":"Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response","volume":"462","author":"Hase","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.03.007_bb0270","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/ni.2352","article-title":"The Ets transcription factor Spi-B is essential for the differentiation of intestinal microfold cells","volume":"13","author":"Kanaya","year":"2012","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0275","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1053\/j.gastro.2011.11.039","article-title":"Peyer's patch dendritic cells sample antigens by extending dendrites through M cell-specific transcellular pores","volume":"142","author":"Lelouard","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2015.03.007_bb0280","doi-asserted-by":"crossref","first-page":"13722","DOI":"10.1073\/pnas.241308598","article-title":"Flagellin stimulation of intestinal epithelial cells triggers CCL20-mediated migration of dendritic cells","volume":"98","author":"Sierro","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0285","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/intimm\/dxq478","article-title":"CCR6hiCD11c(int) B cells promote M-cell differentiation in Peyer's patch","volume":"23","author":"Ebisawa","year":"2011","journal-title":"Int. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0290","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/mi.2012.141","article-title":"The functional maturation of M cells is dramatically reduced in the Peyer's patches of aged mice","volume":"6","author":"Kobayashi","year":"2013","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0295","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2353\/ajpath.2008.070393","article-title":"Resistance of chemokine receptor 6-deficient mice to Yersinia enterocolitica infection: evidence of defective M-cell formation in vivo","volume":"172","author":"Westphal","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.addr.2015.03.007_bb0300","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00292-11","article-title":"Annexin A5 binds to lipopolysaccharide and reduces its endotoxin activity","volume":"3","author":"Rand","year":"2012","journal-title":"mBio"},{"key":"10.1016\/j.addr.2015.03.007_bb0305","doi-asserted-by":"crossref","first-page":"7751","DOI":"10.4049\/jimmunol.179.11.7751","article-title":"Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer's patches with restriction to mucosal compartment","volume":"179","author":"Kadaoui","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0310","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.4049\/jimmunol.172.5.3026","article-title":"Targeting of secretory IgA to Peyer's patch dendritic and T cells after transport by intestinal M cells","volume":"172","author":"Rey","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0315","doi-asserted-by":"crossref","first-page":"e1001658","DOI":"10.1371\/journal.pbio.1001658","article-title":"Dectin-1 is essential for reverse transcytosis of glycosylated SIgA-antigen complexes by intestinal M cells","volume":"11","author":"Rochereau","year":"2013","journal-title":"PLoS Biol."},{"key":"10.1016\/j.addr.2015.03.007_bb0320","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/IAI.01392-06","article-title":"Solitary intestinal lymphoid tissue provides a productive port of entry for Salmonella enterica serovar Typhimurium","volume":"75","author":"Halle","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0325","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.immuni.2007.10.011","article-title":"Entry route of Salmonella typhimurium directs the type of induced immune response","volume":"27","author":"Martinoli","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2015.03.007_bb0330","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1073\/pnas.0409539102","article-title":"Two distinctive pathways for recruitment of naive and primed IgM+ B cells to the gut lamina propria","volume":"102","author":"Suzuki","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0335","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.immuni.2008.05.014","article-title":"Requirement for lymphoid tissue-inducer cells in isolated follicle formation and T cell-independent immunoglobulin A generation in the gut","volume":"29","author":"Tsuji","year":"2008","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2015.03.007_bb0340","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1146\/annurev.immunol.26.021607.090344","article-title":"T follicular helper (TFH) cells in normal and dysregulated immune responses","volume":"26","author":"King","year":"2008","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0345","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1126\/science.1091334","article-title":"Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria","volume":"303","author":"Macpherson","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.03.007_bb0350","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1084\/jem.190.2.229","article-title":"Freshly isolated Peyer's patch, but not spleen, dendritic cells produce interleukin 10 and induce the differentiation of T helper type 2 cells","volume":"190","author":"Iwasaki","year":"1999","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0355","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1132742","article-title":"Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells","volume":"314","author":"Mora","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.03.007_bb0360","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.4049\/jimmunol.171.7.3684","article-title":"CD11b+ Peyer's patch dendritic cells secrete IL-6 and induce IgA secretion from naive B cells","volume":"171","author":"Sato","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0365","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fimmu.2011.00025","article-title":"The role of CD103(+) dendritic cells in the intestinal mucosal immune system","volume":"2","author":"Ruane","year":"2011","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0370","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1084\/jem.20091925","article-title":"Intestinal CD103+, but not CX3CR1+, antigen sampling cells migrate in lymph and serve classical dendritic cell functions","volume":"206","author":"Schulz","year":"2009","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0375","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00281-009-0191-2","article-title":"Th17 cytokines and vaccine-induced immunity","volume":"32","author":"Lin","year":"2010","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.addr.2015.03.007_bb0380","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.4049\/jimmunol.1100402","article-title":"Mucosa-associated epithelial chemokine\/CCL28 expression in the uterus attracts CCR10+ IgA plasma cells following mucosal vaccination via estrogen control","volume":"187","author":"Cha","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0385","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.it.2011.06.003","article-title":"Intestinal CD103+ dendritic cells: master regulators of tolerance?","volume":"32","author":"Scott","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0390","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/mi.2011.61","article-title":"Directed antigen targeting in vivo identifies a role for CD103+ dendritic cells in both tolerogenic and immunogenic T-cell responses","volume":"5","author":"Semmrich","year":"2012","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0395","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1084\/jem.20122762","article-title":"Lung dendritic cells induce migration of protective T cells to the gastrointestinal tract","volume":"210","author":"Ruane","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0400","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.0105-2896.2009.00874.x","article-title":"Development and functional specialization of CD103+ dendritic cells","volume":"234","author":"del Rio","year":"2010","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0405","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/mi.2007.14","article-title":"Differentiation and homing of IgA-secreting cells","volume":"1","author":"Mora","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0410","doi-asserted-by":"crossref","first-page":"5749","DOI":"10.4049\/jimmunol.176.10.5749","article-title":"Redundant role of chemokines CCL25\/TECK and CCL28\/MEC in IgA+ plasmablast recruitment to the intestinal lamina propria after rotavirus infection","volume":"176","author":"Feng","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0415","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/ni.2029","article-title":"Regional and mucosal memory T cells","volume":"12","author":"Sheridan","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0420","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.smim.2008.08.002","article-title":"Role of retinoic acid in the imprinting of gut-homing IgA-secreting cells","volume":"21","author":"Mora","year":"2009","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0425","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nri1439","article-title":"NALT- versus Peyer's-patch-mediated mucosal immunity","volume":"4","author":"Kiyono","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0430","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3109\/08820131003680369","article-title":"Function of mucosa-associated lymphoid tissue in antibody formation","volume":"39","author":"Brandtzaeg","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.addr.2015.03.007_bb0435","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/eji.201041377","article-title":"Memory T cells as an occupying force","volume":"41","author":"Bevan","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0440","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1007\/s10875-010-9368-7","article-title":"Th17 cytokines and the gut mucosal barrier","volume":"30","author":"Blaschitz","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0445","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/mi.2010.60","article-title":"Adaptive immunity in the host-microbiota dialog","volume":"4","author":"Feng","year":"2011","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0450","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/mi.2007.6","article-title":"The immune geography of IgA induction and function","volume":"1","author":"Macpherson","year":"2008","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0455","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.0105-2896.2005.00278.x","article-title":"The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces","volume":"206","author":"Kaetzel","year":"2005","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0460","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1699-0463.1996.tb00724.x","article-title":"Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: critical evaluation of experimental evidence","volume":"104","author":"Kilian","year":"1996","journal-title":"APMIS"},{"key":"10.1016\/j.addr.2015.03.007_bb0465","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3109\/08820131003622635","article-title":"Secretory IgA: arresting microbial pathogens at epithelial borders","volume":"39","author":"Mantis","year":"2010","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.addr.2015.03.007_bb0470","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1016\/j.vaccine.2006.12.001","article-title":"Induction of secretory immunity and memory at mucosal surfaces","volume":"25","author":"Brandtzaeg","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0475","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1038\/nri3322","article-title":"New concepts in the generation and functions of IgA","volume":"12","author":"Pabst","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0480","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.cell.2014.08.006","article-title":"Immunoglobulin A coating identifies colitogenic bacteria in inflammatory bowel disease","volume":"158","author":"Palm","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.addr.2015.03.007_bb0485","doi-asserted-by":"crossref","first-page":"6256","DOI":"10.4049\/jimmunol.177.9.6256","article-title":"Mechanisms of neonatal mucosal antibody protection","volume":"177","author":"Harris","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0490","doi-asserted-by":"crossref","first-page":"8794","DOI":"10.1073\/pnas.0914121107","article-title":"Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine","volume":"107","author":"Tokuhara","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0495","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.coi.2005.06.007","article-title":"Virulence factors, pathogenesis and vaccine protection in cholera and ETEC diarrhea","volume":"17","author":"Sanchez","year":"2005","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0500","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1128\/CMR.14.2.430-445.2001","article-title":"Vaccination strategies for mucosal immune responses","volume":"14","author":"Ogra","year":"2001","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0505","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.vaccine.2013.03.027","volume":"31","author":"Holmgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0510","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.vaccine.2012.12.063","article-title":"Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA\/I overexpressing bacteria and recombinantly produced LTB\/CTB hybrid protein","volume":"31","author":"Lundgren","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0515","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.vaccine.2007.12.009","article-title":"Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae","volume":"26","author":"Tobias","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0520","doi-asserted-by":"crossref","first-page":"e108521","DOI":"10.1371\/journal.pone.0108521","article-title":"Development of Stable Vibrio cholerae O1 Hikojima Type Vaccine Strains Co-Expressing the Inaba and Ogawa Lipopolysaccharide Antigens","volume":"9","author":"Karlsson","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0525","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1128\/CVI.00119-14","article-title":"A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis","volume":"21","author":"Nieves","year":"2014","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0530","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","article-title":"Evaluation of a Outer Membrane Vesicle Vaccine in Nonhuman Primates","volume":"8","author":"Petersen","year":"2014","journal-title":"Procedia Vaccinol."},{"key":"10.1016\/j.addr.2015.03.007_bb0535","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fimmu.2014.00121","article-title":"Bacterial outer membrane vesicles and vaccine applications","volume":"5","author":"Acevedo","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0540","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1073\/pnas.1002348107","article-title":"Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax","volume":"107","author":"Datta","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0545","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/1040841X.2014.962479","article-title":"New approaches in oral rotavirus vaccines","author":"Kuate Defo","year":"2014","journal-title":"Crit. Rev. Microbiol."},{"key":"10.1016\/j.addr.2015.03.007_bb0550","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/bit.25159","article-title":"Bioengineering virus-like particles as vaccines","volume":"111","author":"Lua","year":"2014","journal-title":"Biotechnol. Bioeng."},{"key":"10.1016\/j.addr.2015.03.007_bb0555","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-4889(99)00070-1","article-title":"Membrane traffic and the cellular uptake of cholera toxin","volume":"1450","author":"Lencer","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.addr.2015.03.007_bb0560","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/nrgastro.2011.174","article-title":"New-generation vaccines against cholera","volume":"8","author":"Clemens","year":"2011","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.addr.2015.03.007_bb0565","series-title":"New generation vaccines","first-page":"273","article-title":"Use of genetically or chemically detoxified mutants of cholera and Escherichia coli heat-labile enterotoxins as mucosal adjuvants","author":"Freytag","year":"2010"},{"key":"10.1016\/j.addr.2015.03.007_bb0570","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1128\/MMBR.56.4.622-647.1992","article-title":"Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin","volume":"56","author":"Spangler","year":"1992","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0575","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1615\/CritRevImmunol.v15.i3-4.70","article-title":"The mucosal adjuvant activities of ADP-ribosylating bacterial enterotoxins","volume":"15","author":"Snider","year":"1995","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0580","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1016\/j.vaccine.2010.04.018","article-title":"Mucosal HIV vaccines: a holy grail or a dud?","volume":"28","author":"Azizi","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0585","doi-asserted-by":"crossref","first-page":"e59822","DOI":"10.1371\/journal.pone.0059822","article-title":"The mucosal adjuvant cholera toxin B instructs non-mucosal dendritic cells to promote IgA production via retinoic acid and TGF-beta","volume":"8","author":"Gloudemans","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0590","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1038\/mi.2009.16","article-title":"Cholera toxin B suppresses allergic inflammation through induction of secretory IgA","volume":"2","author":"Smits","year":"2009","journal-title":"Mucosal Immunol."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2015.03.007_bb0595","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/S0264-410X(01)00292-4","article-title":"Pre-clinical and clinical investigation of the safety of a novel adjuvant for intranasal immunization","volume":"20","author":"Glueck","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0600","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1016\/S0264-410X(02)00155-X","article-title":"A dilemma for mucosal vaccination: efficacy versus toxicity using enterotoxin-based adjuvants","volume":"20","author":"Fujihashi","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0605","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0610","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1016\/S0264-410X(00)00553-3","article-title":"Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants","volume":"19","author":"Pizza","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0615","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.4049\/jimmunol.1003789","article-title":"Escherichia coli heat-labile enterotoxin promotes protective Th17 responses against infection by driving innate IL-1 and IL-23 production","volume":"186","author":"Brereton","year":"2011","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0620","doi-asserted-by":"crossref","first-page":"6270","DOI":"10.1128\/IAI.67.12.6270-6280.1999","article-title":"Mutants of Escherichia coli heat-labile toxin act as effective mucosal adjuvants for nasal delivery of an acellular pertussis vaccine: differential effects of the nontoxic AB complex and enzyme activity on Th1 and Th2 cells","volume":"67","author":"Ryan","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0625","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1128\/IAI.67.11.5892-5897.1999","article-title":"Intranasal immunization with pneumococcal polysaccharide conjugate vaccines with nontoxic mutants of Escherichia coli heat-labile enterotoxins as adjuvants protects mice against invasive pneumococcal infections","volume":"67","author":"Jakobsen","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0630","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1046\/j.1365-2567.2000.00090.x","article-title":"Genetically detoxified mutants of heat-labile enterotoxin from Escherichia coli are effective adjuvants for induction of cytotoxic T-cell responses against HIV-1 gag-p55","volume":"101","author":"Neidleman","year":"2000","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2015.03.007_bb0635","doi-asserted-by":"crossref","first-page":"e6999","DOI":"10.1371\/journal.pone.0006999","article-title":"Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin","volume":"4","author":"Lewis","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0640","doi-asserted-by":"crossref","first-page":"e51718","DOI":"10.1371\/journal.pone.0051718","article-title":"The adjuvant double mutant Escherichia coli heat labile toxin enhances IL-17A production in human T cells specific for bacterial vaccine antigens","volume":"7","author":"Leach","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0645","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1128\/IAI.01407-12","article-title":"A double mutant heat-labile toxin from Escherichia coli, LT(R192G\/L211A), is an effective mucosal adjuvant for vaccination against Helicobacter pylori infection","volume":"81","author":"Sjokvist Ottsjo","year":"2013","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0650","doi-asserted-by":"crossref","first-page":"7077","DOI":"10.1016\/j.vaccine.2014.10.069","article-title":"Safety and immunogenicity of an improved oral inactivated multivalent enterotoxigenic Escherichia coli (ETEC) vaccine administered alone and together with dmLT adjuvant in a double-blind, randomized, placebo-controlled Phase I study","volume":"32","author":"Lundgren","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0655","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.4049\/jimmunol.158.8.3936","article-title":"Genetically engineered nontoxic vaccine adjuvant that combines B cell targeting with immunomodulation by cholera toxin A1 subunit","volume":"158","author":"Agren","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0660","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/mi.2010.54","article-title":"Mucosal adjuvants and long-term memory development with special focus on CTA1-DD and other ADP-ribosylating toxins","volume":"3","author":"Lycke","year":"2010","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0665","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4049\/jimmunol.173.5.3310","article-title":"The cholera toxin-derived CTA1-DD vaccine adjuvant administered intranasally does not cause inflammation or accumulate in the nervous tissues","volume":"173","author":"Eriksson","year":"2004","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0670","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1099\/vir.0.2008\/005470-0","article-title":"CTA1-DD adjuvant promotes strong immunity against human immunodeficiency virus type 1 envelope glycoproteins following mucosal immunization","volume":"89","author":"Sundling","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.addr.2015.03.007_bb0675","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bcp.2014.08.017","article-title":"Harnessing the antibacterial and immunological properties of Mucosal-associated invariant T cells in the development of novel oral vaccines against enteric infections","volume":"92","author":"Abautret-Daly","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.addr.2015.03.007_bb0680","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.coi.2010.04.003","article-title":"Synthetic iNKT cell-agonists as vaccine adjuvants\u2013finding the balance","volume":"22","author":"Cerundolo","year":"2010","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0685","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.celrep.2012.11.016","article-title":"Induction of CD8+ regulatory T cells protects macaques against SIV challenge","volume":"2","author":"Lu","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.addr.2015.03.007_bb0690","doi-asserted-by":"crossref","first-page":"4341","DOI":"10.1016\/j.vaccine.2011.09.061","article-title":"The mechanism of action of MF59 \u2013 an innately attractive adjuvant formulation","volume":"30","author":"O'Hagan","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0695","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0169-409X(00)00124-1","article-title":"Block copolymer micelles for drug delivery: design, characterization and biological significance","volume":"47","author":"Kataoka","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0700","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425247.2011.558081","article-title":"Liposomal vaccine delivery systems","volume":"8","author":"Henriksen-Lacey","year":"2011","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.addr.2015.03.007_bb0705","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1056\/NEJMoa1102287","article-title":"First results of phase 3 trial of RTS, S\/AS01 malaria vaccine in African children","volume":"365","author":"Agnandji","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb0710","doi-asserted-by":"crossref","first-page":"6483","DOI":"10.1016\/j.vaccine.2006.06.033","article-title":"Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS, S\/AS02A","volume":"24","author":"Stewart","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0715","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.2174\/092986712803251584","article-title":"Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes","volume":"19","author":"Silva","year":"2012","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.addr.2015.03.007_bb0720","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0168-3659(99)00097-8","article-title":"Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins","volume":"61","author":"Nakanishi","year":"1999","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.03.007_bb0725","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/j.vaccine.2003.11.008","article-title":"Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition","volume":"22","author":"Foged","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0730","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/cr.2015.9","article-title":"Cationic nanocarriers induce cell necrosis through impairment of Na(+)\/K(+)-ATPase and cause subsequent inflammatory response","volume":"25","author":"Wei","year":"2015","journal-title":"Cell Res."},{"key":"10.1016\/j.addr.2015.03.007_bb0735","doi-asserted-by":"crossref","first-page":"e3116","DOI":"10.1371\/journal.pone.0003116","article-title":"Cationic liposomes formulated with synthetic mycobacterial cordfactor (CAF01): a versatile adjuvant for vaccines with different immunological requirements","volume":"3","author":"Agger","year":"2008","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0740","doi-asserted-by":"crossref","first-page":"e6950","DOI":"10.1371\/journal.pone.0006950","article-title":"A novel liposome-based adjuvant CAF01 for induction of CD8(+) cytotoxic T-lymphocytes (CTL) to HIV-1 minimal CTL peptides in HLA-A*0201 transgenic mice","volume":"4","author":"Gram","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0745","doi-asserted-by":"crossref","first-page":"e5771","DOI":"10.1371\/journal.pone.0005771","article-title":"A liposome-based mycobacterial vaccine induces potent adult and neonatal multifunctional T cells through the exquisite targeting of dendritic cells","volume":"4","author":"Kamath","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0750","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1086\/590670","article-title":"Liposome delivery of Chlamydia muridarum major outer membrane protein primes a Th1 response that protects against genital chlamydial infection in a mouse model","volume":"198","author":"Hansen","year":"2008","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0755","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijpharm.2009.10.043","article-title":"CAF01 liposomes as a mucosal vaccine adjuvant: In vitro and in vivo investigations","volume":"390","author":"Christensen","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.03.007_bb0760","doi-asserted-by":"crossref","first-page":"5304","DOI":"10.1016\/j.vaccine.2011.05.009","article-title":"Mucosal immunization with liposome-nucleic acid adjuvants generates effective humoral and cellular immunity","volume":"29","author":"Henderson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0765","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/1521-4141(200006)30:6<1740::AID-IMMU1740>3.0.CO;2-U","article-title":"Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway","volume":"30","author":"Nakanishi","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0770","doi-asserted-by":"crossref","first-page":"e15225","DOI":"10.1371\/journal.pone.0015225","article-title":"Liposome-coupled antigens are internalized by antigen-presenting cells via pinocytosis and cross-presented to CD8 T cells","volume":"5","author":"Tanaka","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0775","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1023\/A:1016030202104","article-title":"Lectin-bearing polymerized liposomes as potential oral vaccine carriers","volume":"13","author":"Chen","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb0780","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0378-5173(00)00442-7","article-title":"Polysaccharide coated liposomes for oral immunization\u2013development and characterization","volume":"203","author":"Venkatesan","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.03.007_bb0785","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.drudis.2009.02.009","article-title":"The path to a successful vaccine adjuvant\u2013'the long and winding road'","volume":"14","author":"O'Hagan","year":"2009","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.addr.2015.03.007_bb0790","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0169-409X(98)00013-1","article-title":"ISCOMs and other saponin based adjuvants","volume":"32","author":"Cox","year":"1998","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0795","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/jlb.64.6.713","article-title":"ISCOMs: an adjuvant with multiple functions","volume":"64","author":"Sjolander","year":"1998","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.addr.2015.03.007_bb0800","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1016\/j.vaccine.2008.06.024","article-title":"In vivo activity of cationic immune stimulating complexes (PLUSCOMs)","volume":"26","author":"McBurney","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0805","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijpharm.2011.05.026","article-title":"Posintro-HBsAg, a modified ISCOM including HBsAg, induces strong cellular and humoral responses","volume":"414","author":"Schiott","year":"2011","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.03.007_bb0810","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.1016\/j.vaccine.2011.03.090","article-title":"A novel non-toxic combined CTA1-DD and ISCOMS adjuvant vector for effective mucosal immunization against influenza virus","volume":"29","author":"Eliasson","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0815","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1016\/j.vaccine.2006.03.081","article-title":"Induction of protective and mucosal immunity against diphtheria by a immune stimulating complex (ISCOMS) based vaccine","volume":"24","author":"Aguila","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0820","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1128\/IAI.01290-06","article-title":"The combined CTA1-DD\/ISCOMs vector is an effective intranasal adjuvant for boosting prior Mycobacterium bovis BCG immunity to Mycobacterium tuberculosis","volume":"75","author":"Andersen","year":"2007","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb0825","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1586\/erv.10.115","article-title":"Virus-like particles in vaccine development","volume":"9","author":"Roldao","year":"2010","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2015.03.007_bb0830","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/0264-410X(88)90174-0","article-title":"Polyvalent recombinant antigens: a new vaccine strategy","volume":"6","author":"Kingsman","year":"1988","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0835","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s12033-012-9598-4","article-title":"Construction and characterization of virus-like particles: a review","volume":"53","author":"Zeltins","year":"2013","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.addr.2015.03.007_bb0840","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ymeth.2006.05.024","article-title":"Virus-like particles: designing an effective AIDS vaccine","volume":"40","author":"Young","year":"2006","journal-title":"Methods"},{"key":"10.1016\/j.addr.2015.03.007_bb0845","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1002\/eji.200526285","article-title":"A therapeutic vaccine for nicotine dependence: preclinical efficacy, and Phase I safety and immunogenicity","volume":"35","author":"Maurer","year":"2005","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0850","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1021\/bc100367u","article-title":"Surface functionalization of virus-like particles by direct conjugation using azide-alkyne click chemistry","volume":"22","author":"Patel","year":"2011","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.03.007_bb0855","first-page":"1","article-title":"Chemical modification of viruses and virus-like particles","volume":"327","author":"Strable","year":"2009","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0860","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326 years","volume":"199","author":"Wheeler","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0865","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/514105","article-title":"Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast","volume":"176","author":"Lowe","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb0870","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1146\/annurev.med.55.091902.103520","article-title":"Human papillomavirus vaccines and prevention of cervical cancer","volume":"55","author":"Jansen","year":"2004","journal-title":"Annu. Rev. Med."},{"issue":"Suppl. 3","key":"10.1016\/j.addr.2015.03.007_bb0875","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.vaccine.2006.05.110","article-title":"Chapter 12: Prophylactic HPV vaccines: underlying mechanisms","volume":"24","author":"Stanley","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0880","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.copbio.2004.10.005","article-title":"Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs","volume":"15","author":"Felnerova","year":"2004","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.addr.2015.03.007_bb0885","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0264-410X(92)90325-E","article-title":"Immunopotentiating reconstituted influenza virosomes (IRIVs) and other adjuvants for improved presentation of small antigens","volume":"10","author":"Gluck","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0890","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S0140-6736(94)92758-8","article-title":"Immunogenicity of new virosome influenza vaccine in elderly people","volume":"344","author":"Gluck","year":"1994","journal-title":"Lancet"},{"issue":"Suppl. 5","key":"10.1016\/j.addr.2015.03.007_bb0895","doi-asserted-by":"crossref","first-page":"B17","DOI":"10.1016\/S0264-410X(02)00512-1","article-title":"Inflexal V a trivalent virosome subunit influenza vaccine: production","volume":"20","author":"Mischler","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb0900","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0163-7827(99)00017-X","article-title":"IRIV-adjuvanted hepatitis A vaccine: in vivo absorption and biophysical characterization","volume":"39","author":"Zurbriggen","year":"2000","journal-title":"Prog. Lipid Res."},{"key":"10.1016\/j.addr.2015.03.007_bb0905","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.immuni.2011.01.015","article-title":"Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges","volume":"34","author":"Bomsel","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.addr.2015.03.007_bb0910","doi-asserted-by":"crossref","first-page":"741","DOI":"10.4155\/tde.14.52","article-title":"Overcoming barriers in the mucosal delivery of virus-like particle-based vaccines","volume":"5","author":"Herbst-Kralovetz","year":"2014","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.addr.2015.03.007_bb0915","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/14760584.6.5.711","article-title":"Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations","volume":"6","author":"Moser","year":"2007","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.addr.2015.03.007_bb0920","doi-asserted-by":"crossref","first-page":"410","DOI":"10.4161\/hv.27147","article-title":"TLR7 and 9 agonists are highly effective mucosal adjuvants for norovirus virus-like particle vaccines","volume":"10","author":"Hjelm","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.addr.2015.03.007_bb0925","doi-asserted-by":"crossref","first-page":"e41529","DOI":"10.1371\/journal.pone.0041529","article-title":"Intranasal vaccination with murabutide enhances humoral and mucosal immune responses to a virus-like particle vaccine","volume":"7","author":"Jackson","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb0930","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jconrel.2006.08.013","article-title":"Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach","volume":"116","author":"des Rieux","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.03.007_bb0935","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.addr.2011.12.009","article-title":"Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers","volume":"64","author":"Ensign","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0940","doi-asserted-by":"crossref","first-page":"13","DOI":"10.3389\/fcimb.2013.00013","article-title":"Vaccine delivery using nanoparticles","volume":"3","author":"Gregory","year":"2013","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.addr.2015.03.007_bb0945","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0952-7915(00)00120-5","article-title":"Immunological concepts of vaccine adjuvant activity","volume":"12","author":"Schijns","year":"2000","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb0950","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S1286-4579(01)01445-9","article-title":"Microparticle vaccine approaches to stimulate mucosal immunisation","volume":"3","author":"Brayden","year":"2001","journal-title":"Microbes Infect."},{"key":"10.1016\/j.addr.2015.03.007_bb0955","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1073\/pnas.0911748107","article-title":"Nanoparticles reveal that human cervicovaginal mucus is riddled with pores larger than viruses","volume":"107","author":"Lai","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0960","doi-asserted-by":"crossref","first-page":"13803","DOI":"10.1073\/pnas.1305882110","article-title":"Unique insights into the intestinal absorption, transit, and subsequent biodistribution of polymer-derived microspheres","volume":"110","author":"Reineke","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb0965","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/S0142-9612(00)00115-0","article-title":"The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices","volume":"21","author":"Jain","year":"2000","journal-title":"Biomaterials"},{"key":"10.1016\/j.addr.2015.03.007_bb0970","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0169-409X(97)00048-3","article-title":"Biodegradation and biocompatibility of PLA and PLGA microspheres","volume":"28","author":"Shive","year":"1997","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb0975","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1089\/ten.tea.2008.0265","article-title":"Biodegradable meshes printed with extracellular matrix proteins support micropatterned hepatocyte cultures","volume":"15","author":"Woodrow","year":"2009","journal-title":"Tissue Eng. Part A"},{"key":"10.1016\/j.addr.2015.03.007_bb0980","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0939-6411(00)00084-9","article-title":"Biodegradable nanoparticles for oral delivery of peptides: is there a role for polymers to affect mucosal uptake?","volume":"50","author":"Jung","year":"2000","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.03.007_bb0985","doi-asserted-by":"crossref","first-page":"23739","DOI":"10.1074\/jbc.M110.126359","article-title":"Intranasal M cell uptake of nanoparticles is independently influenced by targeting ligands and buffer ionic strength","volume":"285","author":"Rajapaksa","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.addr.2015.03.007_bb0990","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1126\/science.8493576","article-title":"Protection against vaginal SIV transmission with microencapsulated vaccine","volume":"260","author":"Marx","year":"1993","journal-title":"Science"},{"key":"10.1016\/j.addr.2015.03.007_bb0995","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3109\/1061186X.2014.888071","article-title":"Cellulose acetate phthalate microparticles containing Vibrio cholerae: steps toward an oral cholera vaccine","volume":"22","author":"Pastor","year":"2014","journal-title":"J. Drug Target."},{"key":"10.1016\/j.addr.2015.03.007_bb1000","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/0264-410X(94)00008-B","article-title":"Immune responses and protection against Bordetella pertussis infection after intranasal immunization of mice with filamentous haemagglutinin in solution or incorporated in biodegradable microparticles","volume":"13","author":"Cahill","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1005","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/infdis\/jit636","article-title":"Targeted nasal vaccination provides antibody-independent protection against Staphylococcus aureus","volume":"209","author":"Misstear","year":"2014","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.addr.2015.03.007_bb1010","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/0264-410X(96)00063-1","article-title":"Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres","volume":"14","author":"Yan","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1015","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1073\/pnas.0804897106","article-title":"Uptake of particulate vaccine adjuvants by dendritic cells activates the NALP3 inflammasome","volume":"106","author":"Sharp","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb1020","doi-asserted-by":"crossref","first-page":"e1000661","DOI":"10.1371\/journal.ppat.1000661","article-title":"IL-1beta processing in host defense: beyond the inflammasomes","volume":"6","author":"Netea","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.addr.2015.03.007_bb1025","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.it.2011.01.003","article-title":"Inflammasome activation and IL-1beta and IL-18 processing during infection","volume":"32","author":"van de Veerdonk","year":"2011","journal-title":"Trends Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1030","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0264-410X(02)00613-8","article-title":"Oral immunization of adult volunteers with microencapsulated enterotoxigenic Escherichia coli (ETEC) CS6 antigen","volume":"21","author":"Katz","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri1372","article-title":"Hydrophobicity: an ancient damage-associated molecular pattern that initiates innate immune responses","volume":"4","author":"Seong","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1040","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/nbt1332","article-title":"Exploiting lymphatic transport and complement activation in nanoparticle vaccines","volume":"25","author":"Reddy","year":"2007","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.addr.2015.03.007_bb1045","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jconrel.2013.09.007","article-title":"beta-Glucan microparticles are good candidates for mucosal antigen delivery in oral vaccination","volume":"172","author":"De Smet","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.addr.2015.03.007_bb1050","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/IAI.00086-09","article-title":"Distinct patterns of dendritic cell cytokine release stimulated by fungal beta-glucans and toll-like receptor agonists","volume":"77","author":"Huang","year":"2009","journal-title":"Infect. Immun."},{"key":"10.1016\/j.addr.2015.03.007_bb1055","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1021\/bc700329p","article-title":"Characterization of multilayered nanoparticles encapsulated in yeast cell wall particles for DNA delivery","volume":"19","author":"Soto","year":"2008","journal-title":"Bioconjug. Chem."},{"key":"10.1016\/j.addr.2015.03.007_bb1060","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/35092620","article-title":"Immune recognition. A new receptor for beta-glucans","volume":"413","author":"Brown","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.03.007_bb1070","doi-asserted-by":"crossref","first-page":"e91002","DOI":"10.1371\/journal.pone.0091002","article-title":"A population of Langerin-positive dendritic cells in murine Peyer's patches involved in sampling beta-glucan microparticles","volume":"9","author":"De Jesus","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.addr.2015.03.007_bb1075","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1023\/A:1015841715384","article-title":"Controlled delivery systems for proteins based on poly(lactic\/glycolic acid) microspheres","volume":"8","author":"Cohen","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb1080","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.addr.2015.03.007_bb1085","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbm.820110507","article-title":"Degradation rates of oral resorbable implants (polylactates and polyglycolates): rate modification with changes in PLA\/PGA copolymer ratios","volume":"11","author":"Miller","year":"1977","journal-title":"J. Biomed. Mater. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb1090","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.vaccine.2013.01.023","article-title":"Oral administration of an adenovirus vector encoding both an avian influenza A hemagglutinin and a TLR3 ligand induces antigen specific granzyme B and IFN-gamma T cell responses in humans","volume":"31","author":"Peters","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1095","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/1596-3519.55702","article-title":"Adenovirus infection in children with diarrhea disease in Northwestern Nigeria","volume":"6","author":"Aminu","year":"2007","journal-title":"Ann. Afr. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb1100","series-title":"Archivum immunologiae et therapiae experimentalis","article-title":"Novel Transgenic Rice-Based Vaccines","author":"Azegami","year":"2014"},{"key":"10.1016\/j.addr.2015.03.007_bb1105","doi-asserted-by":"crossref","first-page":"10986","DOI":"10.1073\/pnas.0703766104","article-title":"Rice-based mucosal vaccine as a global strategy for cold-chain- and needle-free vaccination","volume":"104","author":"Nochi","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.addr.2015.03.007_bb1110","doi-asserted-by":"crossref","first-page":"6538","DOI":"10.4049\/jimmunol.0901480","article-title":"A rice-based oral cholera vaccine induces macaque-specific systemic neutralizing antibodies but does not influence pre-existing intestinal immunity","volume":"183","author":"Nochi","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1115","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1172\/JCI70266","article-title":"Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection","volume":"123","author":"Tokuhara","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.addr.2015.03.007_bb1120","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejpb.2005.04.002","article-title":"Development of an enteric-coated, layered multi-particulate formulation for ileal delivery of viable recombinant Lactococcus lactis","volume":"61","author":"Huyghebaert","year":"2005","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.addr.2015.03.007_bb1125","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3109\/02652048.2013.808278","article-title":"Repeated dose toxicity study of Vibrio cholerae-loaded gastro-resistant microparticles","volume":"31","author":"Lopez","year":"2014","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.addr.2015.03.007_bb1130","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1023\/A:1018936806278","article-title":"Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration","volume":"10","author":"Aramaki","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb1135","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1292\/jvms.59.1109","article-title":"Application of liposomes for development of oral vaccines: study of in vitro stability of liposomes and antibody response to antigen associated with liposomes after oral immunization","volume":"59","author":"Han","year":"1997","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.addr.2015.03.007_bb1140","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/S0264-410X(99)00140-1","article-title":"PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems","volume":"17","author":"Delgado","year":"1999","journal-title":"Vaccine"},{"issue":"Suppl. 3","key":"10.1016\/j.addr.2015.03.007_bb1145","doi-asserted-by":"crossref","first-page":"S723","DOI":"10.1097\/00005176-200406003-00003","article-title":"Anatomical and cellular basis of immunity and tolerance in the intestine","volume":"39","author":"Mowat","year":"2004","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.addr.2015.03.007_bb1150","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/gast.2000.9192","article-title":"New insights into oral tolerance","volume":"119","author":"Whitacre","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.addr.2015.03.007_bb1155","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1177\/41.11.7691933","article-title":"Differential expression of lectin-binding sites defines mouse intestinal M-cells","volume":"41","author":"Clark","year":"1993","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.addr.2015.03.007_bb1160","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0264-410X(97)00222-3","article-title":"Ulex europaeus 1 lectin targets microspheres to mouse Peyer's patch M-cells in vivo","volume":"16","author":"Foster","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1165","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v18.i4.10","article-title":"Targeted delivery of drugs to the gastrointestinal tract","volume":"18","author":"Lavelle","year":"2001","journal-title":"Crit. Rev. Ther. Drug Carrier Syst."},{"key":"10.1016\/j.addr.2015.03.007_bb1170","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1023\/A:1025061317400","article-title":"Toward targeted oral vaccine delivery systems: selection of lectin mimetics from combinatorial libraries","volume":"20","author":"Lambkin","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb1175","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1016\/j.vaccine.2005.06.031","article-title":"Enhanced mucosal and systemic immune response with intranasal immunization of mice with HIV peptides entrapped in PLG microparticles in combination with Ulex Europaeus-I lectin as M cell target","volume":"23","author":"Manocha","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1180","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nature13823","article-title":"Rapid fucosylation of intestinal epithelium sustains host-commensal symbiosis in sickness","volume":"514","author":"Pickard","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.addr.2015.03.007_bb1185","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1084\/jem.20070607","article-title":"A novel M cell-specific carbohydrate-targeted mucosal vaccine effectively induces antigen-specific immune responses","volume":"204","author":"Nochi","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb1190","first-page":"277","article-title":"Monoclonal antibody-directed targeting of fluorescent polystyrene microspheres to Peyer's patch M cells","volume":"73","author":"Pappo","year":"1991","journal-title":"Immunology"},{"key":"10.1016\/j.addr.2015.03.007_bb1195","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0264-410X(94)00029-M","article-title":"Mucosal IgA response to rectally administered antigen formulated in IgA-coated liposomes","volume":"13","author":"Zhou","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1200","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1023\/A:1011981610840","article-title":"Utilizing bacterial mechanisms of epithelial cell entry: invasin-induced oral uptake of latex nanoparticles","volume":"15","author":"Hussain","year":"1998","journal-title":"Pharm. Res."},{"key":"10.1016\/j.addr.2015.03.007_bb1205","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.4049\/jimmunol.171.9.4717","article-title":"M cell DNA vaccination for CTL immunity to HIV","volume":"171","author":"Wang","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1210","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1084\/jem.137.5.1142","article-title":"Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution","volume":"137","author":"Steinman","year":"1973","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb1215","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1084\/jem.152.4.1070","article-title":"Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes","volume":"152","author":"Nussenzweig","year":"1980","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.addr.2015.03.007_bb1220","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nri2173","article-title":"Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting","volume":"7","author":"Tacken","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1225","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.imlet.2010.03.005","article-title":"Recognition of secretory IgA by DC-SIGN: implications for immune surveillance in the intestine","volume":"131","author":"Baumann","year":"2010","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.addr.2015.03.007_bb1230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201141855","article-title":"A new synthetic TLR4 agonist, GLA, allows dendritic cells targeted with antigen to elicit Th1 T-cell immunity in vivo","volume":"42","author":"Pantel","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1235","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1146\/annurev.immunol.25.022106.141634","article-title":"Mucosal dendritic cells","volume":"25","author":"Iwasaki","year":"2007","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1240","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.addr.2005.07.001","article-title":"The basics and underlying mechanisms of mucoadhesion","volume":"57","author":"Smart","year":"2005","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb1245","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/nmat2784","article-title":"Nanogel antigenic protein-delivery system for adjuvant-free intranasal vaccines","volume":"9","author":"Nochi","year":"2010","journal-title":"Nat. Mater."},{"key":"10.1016\/j.addr.2015.03.007_bb1250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/02648725.2013.801226","article-title":"Nanogel-based antigen-delivery system for nasal vaccines","volume":"29","author":"Yuki","year":"2013","journal-title":"Biotechnol. Genet. Eng. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb1255","doi-asserted-by":"crossref","DOI":"10.1038\/mi.2015.5","article-title":"Nanogel-based pneumococcal surface protein A nasal vaccine induces microRNA-associated Th17 cell responses with neutralizing antibodies against Streptococcus pneumoniae in macaques","author":"Fukuyama","year":"2015","journal-title":"Mucosal Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1260","series-title":"Mucosal vaccine using cationic +nanogel","author":"Kazunari","year":"2010"},{"key":"10.1016\/j.addr.2015.03.007_bb1265","doi-asserted-by":"crossref","first-page":"5221","DOI":"10.1016\/j.vaccine.2011.05.027","article-title":"Intranasal delivery of Norwalk virus-like particles formulated in an in situ gelling, dry powder vaccine","volume":"29","author":"Velasquez","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1270","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0264-410X(00)00094-3","article-title":"Characterization of mucoadhesive microspheres for the induction of mucosal and systemic immune responses","volume":"19","author":"Kunisawa","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.addr.2015.03.007_bb1275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0169-409X(01)00171-5","article-title":"Chitosan as a novel nasal delivery system for vaccines","volume":"51","author":"Illum","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.addr.2015.03.007_bb1280","doi-asserted-by":"crossref","first-page":"S91","DOI":"10.1016\/S0169-409X(01)00180-6","article-title":"Chitosan and its derivatives as intestinal absorption enhancers","volume":"50","author":"Thanou","year":"2001","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.addr.2015.03.007_bb1285","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1002\/eji.201242372","article-title":"The vaccine adjuvant alum inhibits IL-12 by promoting PI3 kinase signaling while chitosan does not inhibit IL-12 and enhances Th1 and Th17 responses","volume":"42","author":"Mori","year":"2012","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1290","first-page":"231","article-title":"When, how, and where can oral cholera vaccines be used to interrupt cholera outbreaks?","volume":"379","author":"Clemens","year":"2014","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.addr.2015.03.007_bb1295","doi-asserted-by":"crossref","first-page":"e1289","DOI":"10.1371\/journal.pntd.0001289","article-title":"Efficacy of a low-cost, inactivated whole-cell oral cholera vaccine: results from 3years of follow-up of a randomized, controlled trial","volume":"5","author":"Sur","year":"2011","journal-title":"PLoS Negl. Trop. Dis."}],"container-title":["Advanced Drug Delivery Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15000423?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169409X15000423?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T05:21:59Z","timestamp":1691644919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169409X15000423"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":257,"alternative-id":["S0169409X15000423"],"URL":"https:\/\/doi.org\/10.1016\/j.addr.2015.03.007","relation":{},"ISSN":["0169-409X"],"issn-type":[{"value":"0169-409X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Delivery strategies to enhance oral vaccination against enteric infections","name":"articletitle","label":"Article Title"},{"value":"Advanced Drug Delivery Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.addr.2015.03.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}